MedTrace Logo

Extended Post Anaesthetic Care in PACU During COVID-19: Multi-perspective Value-based Analysis

NCT04717089 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 299

Last updated 2023-06-28

No results posted yet for this study

Summary

To evaluate the value-based effectiveness of the implementation of TMH Extended post anaesthetic care in PACU during COVID-19 pandemics by an institutional matched case-control and quantitative survey study Two ordinary recovery beds were converted to an overnight intensive recovery ("Extended post-anesthetic care in PACU") within the operating theatre complex of Tuen Mun Hospital during COVID-19 pandemics, in an attempt to free the ICU bed and resources from postoperative patients. This study was designed to evaluate the efficacy and staff perceptions towards the abrupt implementation of TMH extended post-anesthetic care in PACU by mobilization of the existing OT resources to cope with the COVID-19 emergency situations. The value-based analysis would look into the implementation effectiveness in twofold: 1) the clinical efficacy using a case-control audit on clinical outcomes and 2) the staff acceptance by means of the staff attitudes survey. Hopefully, this would provide a multi-perspective evaluation of the implementation strategies and aid planning of new services in the future.

Conditions

  • Overnight Intensive Recovery
  • Postoperative Care

Interventions

OTHER

overnight intensive recovery / extended post anaesthetic care in PACU

From January 2020, during COVID-19 first pandemics in Hong Kong, a bundle of interim measures was implemented with the joint efforts of the Department of Anaesthesia and Operating Theatre Services (A\&OT) and Intensive Care Unit (ICU), and two ordinary recovery beds were converted into extended post anesthetic care in PACU (ExRR), based on the concept of overnight intensive recovery (OIR) to provide level 2 intensive care to patients undergoing major or ultra-major operations or having multiple comorbidities warranted intensive care in the immediately postoperative periods. This was conducted over 3 pandemic waves in Hong Kong.

Sponsors & Collaborators

  • Anaesthesia & Operation Theatre Service, Tuen Mun Hospital, Hong Kong

    collaborator UNKNOWN

  • Intensive Care Unit, Tuen Mun Hospital, Hong Kong

    collaborator UNKNOWN

  • Tuen Mun Hospital

    lead OTHER_GOV

Principal Investigators

  • Carmen Lam · Tuen Mun Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-10
Primary Completion
2021-02-28
Completion
2021-06-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04717089 on ClinicalTrials.gov